Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes
Nilay Gandhi(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Leonardo Oliveira Reis(Johns Hopkins University), Mohammad Obaidul Hoque(Johns Hopkins University), Enrico Munari(University of Brescia), David M. Berman(Howard Hughes Medical Institute), Alexander S. Baras(Johns Hopkins University), George J. Netto(University of Pennsylvania), Mark Schoenberg(Montefiore Medical Center), Jen-Jane Liu(Johns Hopkins University), Sheila F. Faraj(Howard Hughes Medical Institute), Noah M. Hahn(Johns Hopkins University), Max Kates(Duke Medical Center), Mario A. Eisenberger(Johns Hopkins University)
Cited by 39
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k